SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs&Pharma - Quaterly Results

14 Feb 2024 Evaluate
The revenue slipped marginally during the December 2023 quarter. A decline of about Rs. 0.35 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended December 2023 is Rs. -0.26 millions as compared to Net Loss of Rs. -0.02 millions of corresponding quarter ended December 2022 Operating profit Margin for the quarter ended December 2023 further decreased to -0.21% as compared to -0.02% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 0.35 0.00 0.00 0.35 0.00 0.00 0.00 1.05 0.00
Other Income 0.01 0.07 -85.71 0.03 0.16 -81.25 2.37 0.00 0.00
PBIDT -0.21 -0.02 950.00 -1.41 -0.66 113.64 1.05 0.24 337.50
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.21 -0.02 950.00 -1.41 -0.66 113.64 1.05 0.24 337.50
Depreciation 0.05 0.00 0.00 0.15 0.00 0.00 0.03 0.00 0.00
PBT -0.26 -0.02 1200.00 -1.56 -0.66 136.36 1.02 0.24 325.00
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.26 -0.02 1200.00 -1.56 -0.66 136.36 1.02 0.24 325.00
Equity 134.39 134.39 0.00 134.39 134.39 0.00 134.39 121.19 10.89
PBIDTM(%) -60.00 0.00 0.00 -402.86 0.00 0.00 0.00 22.86 0.00

Welcure Drugs&Pharma Share Price

0.31 -0.01 (-3.13%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 227.50
Adani Enterprises 2228.00
Amrapali Industries 17.36
Rashi Peripheral 474.40
PDS 294.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×